Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Terce Laboratories has received trading approval from BSE for 3,71,000 equity shares with a face value of Rs. 10 each. These shares were allotted to Mr. Aalap Prajapati (a promoter) upon conversion of warrants previously issued on a preferential basis, at a premium of Rs. 27.70 per share. The shares bear distinctive numbers from 74,20,301 to 77,91,300 and began trading on the exchange from Wednesday, February 25, 2026. This is a follow-through intimation confirming that the warrant conversion process is now complete and the resulting shares are freely tradable.
For shareholders, this means a small increase in the total share count due to the promoter allotting shares, which could lead to minor dilution. There is no direct cash inflow or outflow for existing shareholders from this event.